Table 1 Relationships of SMYD2 and clinicopathological characteristics in 85 patients with cervical cancer
From: SMYD2 promotes cervical cancer growth by stimulating cell proliferation
| Feature | All n = 85 | SMYD2 expression | χ2 | P | |
|---|---|---|---|---|---|
| High | Low | ||||
| n = 60 | n = 25 | ||||
| Age (years) | 0.400 | 0.708 | |||
| < 40 | 45 | 30 | 15 | ||
| ≥ 40 | 40 | 30 | 10 | ||
| FIGO stage | 4.896 | 0.027* | |||
| IB1 | 42 | 25 | 17 | ||
| IB2-IIB | 43 | 35 | 8 | ||
| Differentiation | 2.539 | 0.111 | |||
| Well/moderately | 50 | 32 | 18 | ||
| Poorly | 35 | 28 | 7 | ||
| Tumor size (cm) | 5.773 | 0.016* | |||
| < 4 | 55 | 34 | 21 | ||
| ≥ 4 | 30 | 26 | 4 | ||